According to the different levels of anti-GPL-core IgG between the SGM and RGM groups in our study, most patients who had an intermediate level of anti-GPL-core IgG (4.140–7.955 AU/ml) could be identified as RGM infection (11/12, 92%). The gene discussed is IL31RA; the disease is infection.